When Saurabh Arora talks about Lybrate’s achievements, his demeanour is calm and content. His tone oscillates between assured and enthusiastic as he narrates the story of Lybrate—how he brought the most funded startup in the telemedicine space to life. As soon as the subject of competition arises, Arora suddenly shifts to an alert, almost feline defence mode. He has marked his territory. If someone wants to enter it, he needs to know who that is.

Lybrate’s closest competitor Doctor Insta has raised one-fourth of its funding and built a business model inclined towards serving businesses, not users directly. It’s nowhere near becoming a threat to Lybrate. “Real competition,” Arora, founder of Lybrate, believes, “is the guy in the next room, who has the next big idea. Who is thinking out of the box, solving problems we have not yet been able to.”

Arora does not know, yet. It is not the ‘next big idea’ that he will soon compete with. His competition will be the sheer number of users backed by infinite resources. Will Lybrate be able to prepare for what is to come? In short, Jio.

Earlier this year, Reliance quietly launched the JioHealthHub app, exclusively for Jio subscribers. Arora shows the app on his phone. It is just a health data storage app, in beta version. He knows that, but what he doesn’t know is that soon it will bring the doctor to the phone screen. The JioHealthHub app, according to Google Play, has been downloaded between 100,000 and 500,000 times so far. A tenth of Lybrates’ reach at best. But Jio considers each of the 100 million users as potential customers. And converting them to app users is just a matter of time, is Reliance Jio’s motto. Once out of beta testing, the company plans pre-installing the app for every Jio subscriber. And once it gets doctors on the app, JioHealthHub will become ready to compete with Lybrate.

An image of JioHealthHub's introductory page (Screenshots are disabled on the app)

Meanwhile, with $11.4 million from Tiger Global, Nexus Venture Partners and Ratan Tata, Lybrate has proved that there’s a compelling need for teleconsultations between patients and doctors. Since its launch in January 2015, the app has convinced 100,000 doctors to provide e-consultations. It claims that it has 4.5 million downloads and serves as a platform for 6 million interactions a month by way of searches for doctors, health queries and patient-doctor communication. (The Ken could not independently verify these numbers.)

Earning doctors

Since its launch in January 2015, the Lybrate app has convinced 100,000 doctors to provide e-consultations. It claims that it has 4.5 million downloads and serves as a platform for 6 million interactions a month by way of searches for doctors, health queries and patient-doctor communication

Neither is focused on profits or more users, just yet.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?

MOST POPULAR

Annual Subscription

12-month access to 200+ stories, archive of 800+ stories from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 2,750

Subscribe
 

Quarterly Subscription

3-month access to 60+ new stories with 3-months worth of archives from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 1,750

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

Rs. 500

Subscribe
MOST POPULAR

Annual Subscription

12-month access to 150+ stories from Southeast Asia.

$ 120

Subscribe
 

Quarterly Subscription

3-month access to 35+ stories from Southeast Asia.

$ 50

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

$ 20

Subscribe

Questions?

What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

For subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.